Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Other assay [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-24415 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- IFNA13 Monoclonal Antibody (3F9)
- Antibody type
- Monoclonal
- Antigen
- Recombinant full-length protein
- Description
- Peptide Sequence: FTTKDSSAAW DEDLLDKFCT ELYQQLNDLE ACVMQEERVG ETPLMNADSI LAVKKYFRRI TLYLTEKKYS PCAWEVVRAE IMRSLSLSTN LQERLRRKE
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 3F9
- Vial size
- 100 µg
- Concentration
- 1.0 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references A short deletion in the DNA-binding domain of STAT3 suppresses growth and progression of colon cancer cells.
Xiong YJ, Liu DY, Shen RR, Xiong Y
Aging 2021 Feb 1;13(4):5185-5196
Aging 2021 Feb 1;13(4):5185-5196
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- ELISA analysis using recombinant GST tagged IFN Alpha 13 Antibody (Product # MA5-24415) at 0.3 ng/mL as the capture antibody.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 3 STAT3 del reduces in vitro growth, survival and migration of colon cancer cells. ( A ) CCK8 assay results show the proliferation rate of SW480, SW620 and HCT-116 cells with wild type STAT3 or STAT3 del . ( B ) TUNEL assay results show the apoptotic rate of SW480, SW620 and HCT-116 cells with wild type STAT3 or STAT3 del . ( C ) Wound healing assay results show the migration rate of SW480, SW620 and HCT-116 cells with wild type STAT3 or STAT3 del . * denotes p